D.C. Medical Marijuana Program Tops 90,800 Patients in November as Dispensary Sales Double From Last Year

Patient participation and overall program enrollment in Washington, D.C.’s medical marijuana program  continued to climb in November, according to new data released by the Alcoholic Beverage and Cannabis Administration. Licensed dispensaries reported a total of $5.71 million in sales in November, down slightly from October but still well above September levels and roughly double the $2.85 million sold in November 2024. Delivery sales reached $229,479, compared to $233,497 in October and $220,983 in September.

The average transaction rose to $64 in November, up from $63 in both October and September, indicating stronger per-sale spending despite fewer total transactions.

Among DC residents, the number of unique medical marijuana patients continued to rise, reaching 20,761 in November, an increase from both September and October. Total unique sales for DC residents declined slightly to 54,726, but delivery orders edged higher, suggesting a gradual shift in purchasing behavior. Delivery transactions averaged $141 per sale, compared to $61 for in-store purchases.

Non-DC residents participating through reciprocity programs also showed renewed activity. Total sales from visiting patients rose to $464,895 in November, rebounding from October’s dip. Maryland and Virginia once again accounted for the largest share of out-of-state patients, followed by Florida, Pennsylvania and Massachusetts.

Temporary self-certified registrations, which allow non-residents short-term access to DC’s medical marijuana system, declined from October highs but remained elevated compared to September. These patients generated $1.76 million in sales during November, with average purchase amounts climbing to $102, reflecting larger per-transaction spending.

Across the broader supply chain, total cannabis-related sales—including dispensaries, cultivation centers and manufacturers—reached $8.47 million in November. While that figure was slightly below October’s $8.96 million, it marked a dramatic increase compared to November of last year, when total sales stood at just over $4.02 million.

Flower remained the dominant product category by a wide margin, generating more than $3.03 million in sales, while vape cartridges surpassed $1.05 million. Edibles also continued their steady growth, topping $677,000 for the month.

Program participation overall continued its upward trajectory, with more than 90,800 unique patients registered by the end of November, an increase of about 6,250 compared to the previous month.

Healthcare provider participation also ticked higher, with the number of registered healthcare providers increasing from 660 in October to 666 in November, reinforcing the program’s continued expansion even amid short-term sales fluctuations.